Golden State Wealth Management LLC Makes New $691,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Golden State Wealth Management LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,163 shares of the biotechnology company's stock, valued at approximately $691,000.

Other large investors have also recently bought and sold shares of the company. Groupama Asset Managment acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA bought a new stake in Axon Enterprise in the third quarter valued at approximately $120,553,000. International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $871,860,000. Westfield Capital Management Co. LP boosted its stake in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock worth $469,661,000 after acquiring an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. increased its holdings in shares of Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock worth $86,354,000 after acquiring an additional 111,405 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON traded down $8.59 during mid-day trading on Tuesday, reaching $669.26. The company had a trading volume of 421,444 shares, compared to its average volume of 566,679. Axon Enterprise, Inc. has a one year low of $255.68 and a one year high of $698.67. The business's 50-day simple moving average is $624.25 and its 200 day simple moving average is $501.43. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market cap of $51.03 billion, a price-to-earnings ratio of 172.94, a PEG ratio of 6.79 and a beta of 1.05.

Analysts Set New Price Targets

Several equities research analysts have issued reports on AXON shares. Northland Securities raised their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a report on Monday, November 11th. The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Robert W. Baird upped their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $542.15.

Insider Buying and Selling at Axon Enterprise

In related news, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now directly owns 2,392 shares of the company's stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock valued at $5,631,561 in the last ninety days. 6.10% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.